Showing all 4 results
Desvenlafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Desvenlafaxine Succinate USP/Ph.Eur.
(Equivalent to Desvenlafaxine base)50 mg (ER) The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder. Desvenlafaxine Succinate USP/Ph.Eur. 100 mg (ER) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric Film Hydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).
Duloxetine Capsules
FreeDuloxetine capsules are delayed-release (gastro-resistant) medications used to treat depression, anxiety, and chronic pain. Because the medicine can be destroyed by stomach acid, it is formulated as acid-resistant pellets inside a hard gelatin capsule.
Venalafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Extended-Release (ER) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the controlled-release polymer matrix.
Active Ingredient Strength Primary Clinical Use Venlafaxine Hydrochloride USP/BP/Ph.Eur. 37.5 mg (Extended-Release) Mandatory initiation dose for severe panic disorder and strict tapering/weaning protocols. Venlafaxine Hydrochloride USP/BP/Ph.Eur. 75 mg (Extended-Release) Standard Adult Dose for initiating therapy in Major Depressive Disorder and GAD. Venlafaxine Hydrochloride USP/BP/Ph.Eur. 150 mg (Extended-Release) High-dose SNRI therapy for treatment-resistant depression and severe social anxiety. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release) Venlafaxine Capsules
FreeVenlafaxine capsules, most commonly available as extended-release (ER/XR) formulations, contain the active drug in the form of small medicine-filled pellets or mini-tablets. These are designed to release the medication slowly into your system over 24 hours.
